Nesuparib
Nesuparib (JPI-547/OCN-201) is a dual PARP/TNKS1 inhibitor with demonstrated antitumor activity in preclinical research. Its application extends to studies in oncology, metabolic disorders, and neurological conditions, supported by evidence from both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2055357-64-5
Product Name Alternative
Beta-catenin, betacatenin, bcatenin, JPI-547/OCN 201, JPI-547/OCN201, JPI-547/OCN-201, PARP, Nesuparib, TNKS1, Wnt/b-catenin, Wnt/betacatenin, Wnt/β-catenin, Wnt, βcatenin
Field of Research
Epigenetics & Chromatin, Molecular Biology, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.71% (May vary between batches)
Solubility
DMSO:56.2 mg/mL (140.33 mM)
Smiles
O=c1[nH]c2cc (CN3CCN (CC3) c3ccc (cn3) C#N) ccc2c2NCCCc12
Molecular Formula
C23H24N6O
Molecular Weight
400.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog